38 Active Studies

Preeclampsia Clinical Trials Near You

Find 38 actively recruiting preeclampsia research studies near you. Connect with study sites, check eligibility, and explore new treatment options.

38Active Trials
43+Locations
47,504Participants Needed

Recruiting Studies

Advanced Search

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Top Cities for Preeclampsia Clinical Trials

Preeclampsia clinical trials are recruiting across 43 cities. Here are the cities with the most active studies:

Preeclampsia Trial Phases

NA(7 studies)
PHASE4(6 studies)
PHASE2(6 studies)
EARLY_PHASE1(6 studies)
PHASE3(2 studies)

28 research organizations are sponsoring preeclampsia trials.

About Preeclampsia

Preeclampsia is a pregnancy complication characterized by high blood pressure and signs of damage to organs, most often the liver and kidneys. It usually develops after 20 weeks of pregnancy and can be life-threatening. Treatment may include early delivery, blood pressure medications, and close monitoring.

Clinical trials are advancing new treatments for preeclampsia. Currently, 38 studies are recruiting a combined 47,504 participants across the United States. Research is being conducted by 28 organizations including Preeclampsia Foundation, Ohio State University, Sequenom, Inc. and 25 others.

2026 Preeclampsia Research Landscape

As of July 2026, the preeclampsia clinical trial landscape includes 38 actively recruiting studies across 43 cities in the United States. These studies are collectively seeking 47,504 participants, with an average enrollment target of 1,250 per study.

The research spans multiple phases of development: 7 studies are in NA, 6 studies are in PHASE4, 6 studies are in PHASE2, 6 studies are in EARLY_PHASE1, 2 studies are in PHASE3. The presence of Phase 3 trials indicates that some preeclampsia treatments are in late-stage testing and may be approaching regulatory review.

Research is being led by 28 different organizations, including Preeclampsia Foundation, Ohio State University, Sequenom, Inc., University of Pennsylvania, University of California, San Diego, and 23 others. The large number of sponsors reflects significant research interest and investment in preeclampsia treatment advancement.

Geographically, preeclampsia trials are most concentrated in New York, New York (5 trials); Iowa City, Iowa (5 trials); Birmingham, Alabama (4 trials); Chicago, Illinois (4 trials); Columbus, Ohio (3 trials) and 7 other cities.

Featured Preeclampsia Studies

Highlighted recruiting studies for preeclampsia, selected by enrollment size and research scope.

RecruitingNCT06377878

The Preeclampsia Registry

The purpose of The Preeclampsia Registry is to collect and store medical and other information from women who have been medically diagnosed with preeclampsia or a related hypertensive (high blood pressure) disorder of pregnancy such as eclampsia or HELLP syndrome, their family members, and women who have not had preeclampsia to serve as controls. Information from participants will be used for medi...

Sponsor: Preeclampsia Foundation· 20,000 participants· 1 location (Melbourne)
View full study details →
RecruitingNCT06468202 · PHASE4

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

The overall goal of this large, pragmatic, comparative effectiveness trial is to test the hypothesis that among at-risk individuals, 162 mg/day aspirin is superior to 81 mg/day in preventing Hypertensive disorders of pregnancy (HDP), and that there are multiple factors associated with adherence with aspirin therapy that will be important to identify to enable optimal implementation of study findin...

Sponsor: Ohio State University· 10,742 participants· 10 locations (Birmingham, Los Angeles, San Francisco, Chicago)
View full study details →
RecruitingNCT06643741

Non-Invasive Preeclampsia Screening and Biobank

Women pregnant between 11-14 weeks gestation will be enrolled with blood samples collected to evaluate for preeclampsia.

Sponsor: Sequenom, Inc.· 6,550 participants· 10 locations (Glendale, Newark, Miami, Metairie)
View full study details →

Frequently Asked Questions About Preeclampsia Clinical Trials

Are there preeclampsia clinical trials near me?

Yes, there are 38 preeclampsia clinical trials currently recruiting across 43+ cities in the United States, including New York, New York; Iowa City, Iowa; Birmingham, Alabama. Browse the studies above to find one at a location convenient for you.

How do I join a preeclampsia clinical trial?

To join a preeclampsia clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.

Are preeclampsia clinical trials free?

Yes, participation in preeclampsia clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.

What types of preeclampsia treatments are being studied?

Current preeclampsia clinical trials are testing a range of approaches across NA (7 studies), PHASE4 (6 studies), PHASE2 (6 studies), EARLY_PHASE1 (6 studies), PHASE3 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 28 research organizations.

Is it safe to participate in preeclampsia clinical trials?

Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.

Data updated July 15, 2026 from ClinicalTrials.gov

About This Data

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.

Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.

Page reviewed by the HelloStudys Research Team · Last updated July 15, 2026 · Data from ClinicalTrials.gov